The National Heart, Lung, and Blood Institute awarded an indefinite-delivery contract to Vitalant (doing business as Vitalant Research Institute) on September 30, 2026, for the Recipient Epidemiology and Donor Evaluation Study (REDS) regional hubs, with a ceiling of $7.416 million and ultimate completion date of September 29, 2033. This is a multiple-award IDIQ.
Work is performed in Scottsdale, Arizona. The contract supports specialized research and development services in transfusion medicine and epidemiological study administration, classified under NAICS 541715 (research and development services) and PSC AN11 (health research and development).
The period of performance runs through September 29, 2033. A delivery order issued under this IDIQ on September 30, 2026, carries a ceiling of $4.9 million and cost-no-fee pricing, also with September 29, 2033 completion.
Vitalant Research Institute, the research and specialized services division of Vitalant, operates as the nation's largest independent nonprofit blood services provider, delivering blood collection, processing, testing, and transfusion medicine research services to federal healthcare agencies across approximately 900 hospitals in 28 states. The organization competes in open, unrestricted federal procurement with no set-aside designations.